StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Piperazindihydrochlorid

Piperazine Dihydrochloride

HCID 8893
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
142-64-3
Standard-SMILES
C1CNCCN1.Cl.Cl
InChIKey
CVVIJWRCGSYCMB-UHFFFAOYSA-N
Summenformel
C4H10N2.2ClH
Durchschnittliche Molmasse
159,05 g/mol
Monoisotopische Masse
158,0377538

Überblick

Piperazine dihydrochloride appears as white to cream-colored needles or powder. Mp: 318-20 °C (with decomposition).

Namen und Bezeichner

Bevorzugter Name
Piperazine Dihydrochloride
IUPAC
piperazine;dihydrochloride
Lokaler Name
Piperazindihydrochlorid
Englischer Name
PIPERAZINE DIHYDROCHLORIDE
Summenformel
C4H12Cl2N2
Molmasse
159.06

Namen und Synonyme

Piperazine dihydrochloride142-64-3Dowzene DHCPiperazine, dihydrochloridePiperazine wormer premixDihydro Pip WormerDiethylenediamine dihydrochlorideDTXSID4047096Ascarex DDihydrochloride salt of diethylenediamine17VU4Z4W88DTXCID2027096
Weitere Namen anzeigen
Piperazine 2HClPipDCldowzenedhcdihydropipwormerPIPERAZINE DI HCLpiperazinewormerpremixPiperazine hydrate CRSpiperazinehydrochloridePiperazinium Dichloride
Piperazine, hydrochloride (1:2)RefChem:58255205-551-2piperazine;dihydrochlorideMFCD00012754Piperazine dihydrochloride [USP]Piperazinium chlorideCaswell No. 668

Datenbank-Bezeichner

CAS
142-64-3、7542-23-6
PubChem CID
8893

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

Polarare Oberfläche (TPSA)
24,1 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
0
Schwere Atome
8
Formalladung
0
Komplexität
26,5

Experimentelle und physikochemische Eigenschaften

Chemical ClassesNitrogen Compounds -> Piperazines
Food AdditivesUse unspecified -> FDA Substance added to food
Color/Form · 3 Einträge

CREAM COLORED CRYSTALLINE POWDER

WHITE NEEDLES

White to creamy colored needles or powder.

Solubility · 3 Einträge

41 % (NIOSH, 2024)

SOLUBILITY IN WATER: 35% @ 0 °C, 41% @ 20 °C, 48% @ 50 °C; INSOL IN ORGANIC SOLVENTS

41%

Animal DrugsFDA approved animal drugs -> Active ingredient
DecompositionWhen heated to decomposition it emits very toxic fumes of nitrous oxide and hydrogen chloride.
Melting Point · 3 Einträge

635 °F (NIOSH, 2024)

635 °F

635 °F

Physical Description · 4 Einträge

Piperazine dihydrochloride appears as white to cream-colored needles or powder. Mp: 318-20 °C (with decomposition).

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

Danger

H315: Causes skin irritation [Warning Skin corrosion/irritation]

P203, P233, P260, P261, P264, P264+P265, P271, P272, P273, P280, P284, P302+P352, P304+P340, P305+P351+P338, P318, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)

Danger

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P203, P233, P260, P261, P264, P264+P265, P271, P272, P273, P280, P284, P302+P352, P304+P340, P305+P351+P338, P318, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)

Gefahrenhinweise

Regulatory Information · 3 Einträge

Chemical: Piperazine, dihydrochloride

Hazard Traits - Respiratory Toxicity

Piperazine dihydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - Piperazine salts: Human health tier II assessment
Health HazardsExcerpt from NIOSH Pocket Guide for Piperazine dihydrochloride:
Hazards Summary · 1 Eintrag

Piperazine dihydrochloride is well tolerated as an oral medication at a dose of 150 mg/kg for several days. Skin burns, allergic contact dermatitis, and asthma have been reported after occupational exposures to piperazine dust. [ACGIH] Piperazine, CAS # 110-85-0, is corrosive to skin. [Quick CPC] Asthma reported in pharmaceutical and chemical production workers; [Malo] Allergic contact dermatitis reported in pharmaceutical, laboratory, healthcare, and veterinary workers; [Kanerva, p. 1827] See Piperazine and salts.

Chemie und Industrie

Pharmakologische Informationen

Mechanism of ActionANTHELMINTIC ACTION IS BY NARCOTIZING AND IMMOBILIZING INTERNAL PARASITES.
Metabolism/MetabolitesPIPERAZINE IS PARTLY METABOLIZED IN AN UNKNOWN MANNER IN MAN, SINCE ONLY 15% OF 2 G DOSES ARE EXCRETED UNCHANGED. /PIPERAZINE/
MeSH Pharmacological ClassificationSubstances used in the treatment or control of nematode infestations. They are used also in veterinary practice.
Absorption, Distribution and ExcretionNOT ABSORBED THROUGH SKIN IN ACUTE TOXIC AMT.

Verwendung und Herstellung

Uses · 6 Einträge

Used to manufacture fibers, pharmaceuticals, and insecticides; [ACGIH] Used as a veterinary anthelmintic medication and a curing agent for polychloroprene; [HSDB]

Plastic Composites Manufacturing [Category: Industry]

MEDICATION (VET)

MEDICATION

CHEM INT FOR ANTIHISTAMINES

USED IN MAKING INSECTICIDES & FIBERS

U.S. Production · 2 Einträge

(1972) 8.3X10+8 GRAMS

(1975) 7.14X10+8 GRAMS

Consumption PatternsESSENTIALLY 100% FOR ANTHELMINTIC USE (1976)
Methods of ManufacturingCYCLIZATION OF ETHYLENEDIAMINE IN THE PRESENCE OF A METALLIC HYDROGENATION CATALYST, FOLLOWED BY REACTION WITH HYDROCHLORIC ACID
Formulations/Preparations · 3 Einträge

PIPERAZINE DIHYDROCHLORIDE 53% BASE /IS/ POPULAR IN DRY FEED OR DRINKING WATER /ANTHELMINTIC/ MEDICATION.

PIPERTAB 2: COMPOSITION: EACH TABLET CONTAINS: PIPERAZINE DIHYDROCHLORIDE EQUIVALENT TO 50 MG PIPERAZINE BASE. ... AVAILABLE IN 500 TABLET BOTTLES. PIPERTAB 10: COMPOSITION: EACH TABLET CONTAINS: PIPERAZINE DIHYDROCHLORIDE EQUIVALENT TO 250 MG PIPERAZINE BASE.

Zugehörige Reaktionen

6
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 220448
HRID 220448als Edukt
Reaktionsgleichung von HRID 659751
HRID 659751als Edukt
Reaktionsgleichung von HRID 659752
HRID 659752als Edukt
Reaktionsgleichung von HRID 659754
HRID 659754als Edukt
Reaktionsgleichung von HRID 1475277
HRID 1475277als Edukt
Reaktionsgleichung von HRID 2290450
HRID 2290450als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
DTXSID
DTXSID4047096
ChEMBL
CHEMBL3188015
UNII
17VU4Z4W88
EC Number
205-551-2、231-422-5

White to cream-colored needles or powder; [NIOSH]

White to cream-colored needles or powder.

White to cream-colored needles or powder.

Stability/Shelf Life · 2 Einträge

STABLE @ TEMP TO 270 °C & IN NEUTRAL OR ACID MEDIA

Stability of piperazine can be accomplished by use of its simple salts, /including hydrochloride/, which are more stable than the piperazine base.

Other Experimental Properties · 2 Einträge

SLIGHTLY HYGROSCOPIC

82-83 °C /Monohydrate/

Physikochemische Eigenschaften

Schmelzpunkt
320 °C · 320°C(dec.)(lit.)
Siedepunkt
262.01 °C · 262.01°C (rough estimate)
Dichte
1.3011 · 1.3011 (rough estimate)
Brechungsindex
1.63 · 1.6300 (estimate)
storage temp.
Inert atmosphere,Room Temperature
Löslichkeit
Water
Aggregatzustand
White crystalline solid
Farbe
White to Off-White
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C4H10N2.2ClH/c1-2-6-4-3-5-1;;/h5-6H,1-4H2;2*1H
InChIKey
CVVIJWRCGSYCMB-UHFFFAOYSA-N
SMILES
C1NCCNC1.Cl.Cl
LogP
-1.171 · -1.171 (est)
CAS Datenbank
142 · 142-64-3(CAS DataBase Reference)
EPA chemische Informationen
Piperazine dihydrochloride (142-64-3)
FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Reactive GroupSalts, Acidic
Reactivity ProfileThis compound is incompatible with the following: Water, HEAT, flames, oxidizers. It absorbs moisture from air. It may create flammable condition upon contact with HEAT, FLAMES and OXIDIZERS.
Flammable LimitsCombustible Solid, but does not ignite easily.
Air and Water ReactionsNo rapid reaction with air. No rapid reaction with water. Soluble in water.
NIOSH RecommendationsRecommended Exposure Limit: 10 Hr Time-Weighted Avg: 5 mg/cu m.
Hazard Classes and Categories · 4 Einträge

Skin Irrit. 2 (100%)

Eye irritation - category 2A

Acute toxicity (Oral) - Category 5

Repr. 2

Hazardous Reactivities and Incompatibilities · 2 Einträge

Water [Note: Slightly hygroscopic (i.e., absorbs moisture from the air)].

Water [Note: Slightly hygroscopic (i.e., absorbs moisture from the air).]

Sicherheit und Schutzausrüstung

First Aid · 2 Einträge

Excerpt from NIOSH Pocket Guide for Piperazine dihydrochloride:

(General first aid procedures)

Disposal Methods · 1 Eintrag

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Preventive Measures · 5 Einträge

If material not on fire and not involved in fire: Keep sparks, flames, and othersources of ignition away. Keep material out of water sources and sewers. Build dikes to contain flow as necessary. /Piperazine/

Personnel protection: Avoid breathing vapors. Keep upwind. ... Avoid bodily contact with the material. ... Do not handle broken packages unless wearing appropriate personal protective equipment. Wash away any material which may have contacted the body with copious amounts of water or soap and water. If contact with the material anticipated, wear appropriate chemical protective clothing. /Piperazine/

The worker should immediately wash the skin when it becomes contaminated.

Work clothing that becomes wet or significantly contaminated should be removed and replaced.

Workers whose clothing may have become contaminated should change into uncontaminated clothing before leaving the work premises.

Respirator RecommendationsImportant additional information about respirator selection
Threshold Limit Values (TLV) · 3 Einträge

8 hr Time Weighted Avg (TWA): 5 mg/cu m.

Excursion Limit Recommendation: Excursions in worker exposure levels may exceed 3 times the TLV-TWA for no more than a total of 30 minutes during a work day, and under no circumstances should they exceed 5 times the TLV-TWA, provided that the TLV-TWA is not exceeded.

0.03 ppm (inhalable fraction and vapor) [2011]

Permissible Exposure Limit (PEL)none See Appendix G
Recommended Exposure Limit (REL) · 2 Einträge

5 mg/m³

TWA 5 mg/m3

Personal Protective Equipment (PPE) · 5 Einträge

Excerpt from NIOSH Pocket Guide for Piperazine dihydrochloride:

Wear appropriate personal protective clothing to prevent skin contact.

Wear appropriate eye protection to prevent eye contact.

Eyewash fountains should be provided in areas where there is any possibility that workers could be exposed to the substance; this is irrespective of the recommendation involving the wearing of eye protection.

Facilities for quickly drenching the body should be provided within the immediate work area for emergency use where there is a possibility of exposure. [Note: It is intended that these facilities provide a sufficient quantity or flow of water to quickly remove the substance from any body areas likely to be exposed. The actual determination of what constitutes an adequate quick drench facility depends on the specific circumstances. In certain instances, a deluge shower should be readily available, whereas in others, the availability of water from a sink or hose could be considered adequate.]

Immediately Dangerous to Life or Health (IDLH)N.D.

Toxikologische Informationen

Interactions · 1 Eintrag

IN ISOLATED FROG & RABBIT HEARTS PIPERAZINE PRODUCED BIPHASIC EFFECT WITH INITIAL NEG INOTROPIC ACTION FOLLOWED BY POS INOTROPIC ACTION. FORMER PHASE WAS ANTAGONIZED BY ATROPINE, HEXAMETHONIUM & DIGOXIN. DIRECT ACTION ON THE HEART IS SUGGESTED. /PIPERAZINE HYDROGEN CHLORIDE/

Target OrgansEyes, skin, respiratory system, central nervous system
Adverse EffectsDermatotoxin - Skin burns.
Exposure Routesinhalation, skin absorption, ingestion, skin and/or eye contact
Signs and Symptomsirritation eyes, skin, respiratory system; skin burns, sensitization; asthma; gastrointestinal upset, headache, nausea, vomiting, incoordination, muscle weak
Human Toxicity Excerpts · 4 Einträge

... SIDE EFFECTS ... INCL HEADACHES, NAUSEA, VOMITING, DIARRHEA, LETHARGY, TREMOR, INCOORDINATION, MUSCULAR WEAKNESS ... & VAGUE OCULAR DISTURBANCES. /PIPERAZINE SALTS/

LOSS OF CONSCIOUSNESS, DYSARTHRIA, APRAXIA, CLONIC SPASMS, TREMOR, MUSCULAR WEAKNESS, DROPPING OF OBJECTS, INABILITY TO THINK CLEARLY &/OR HALLUCINATIONS SEEN IN 35 YR OLD PT WITH TERMINAL RENAL FAILURE TAKING 30 MG PIPERAZINE HEXAHYDRATE/KG BODY WT/DAY FOR 10 DAYS. /PIPERAZINE HEXAHYDRATE/

SEVERE ILLNESS OCCURRED IN A 25 YR OLD WOMAN AFTER ADMIN OF PIPERAZINE ON 2 SEPARATE OCCASIONS. EVIDENCE FAVORS A HYPERSENSITIVITY MECHANISM RATHER THAN A DIRECT TOXIC EFFECT OF DRUG OR ITS METABOLITES. /PIPERAZINE/

ACUTE HUMAN EXPOSURES HAVE RESULTED IN MILD TO MODERATE SKIN BURNS & SENSITIZATION. MILD TO MODERATE ASTHMA HAS BEEN ASSOCIATED WITH INHALATION OF DUST.

Non-Human Toxicity Excerpts · 3 Einträge

EYE CONTACT, MARKED PAIN AND MODERATE EYE IRRITATION WHICH HEALS IN 2 DAYS WITH NO CORNEAL INJURY. SKIN CONTACT VERY SLIGHT IRRITATION.

VOMITING & DIARRHEA IS OCCASIONALLY REPORTED IN CATS & DOGS ESPECIALLY IF OVERDOSED. /ORAL ADMIN/

IN ISOLATED FROG & RABBIT HEARTS PIPERAZINE PRODUCED BIPHASIC EFFECT WITH INITIAL NEG INOTROPIC ACTION FOLLOWED BY POS INOTROPIC ACTION. FORMER PHASE WAS ANTAGONIZED BY ATROPINE, HEXAMETHONIUM & DIGOXIN. DIRECT ACTION ON HEART IS SUGGESTED. /PIPERAZINE/

Non-Human Toxicity ValuesLD50 Rat oral 4,900 mg/kg

Regulatorische Informationen

FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Sicherheitsdaten

F
3-10
OEB
B
OEL
TWA: 5 mg/m3
wgk
WGK 2
tsca
TSCA listed
hs_code
2933599550
RTECS-Nr.
TL4025000
risk_code
36/37/38-42/43
Toxizität
mouse,LD50,intraperitoneal,1970mg/kg (1970mg/kg),LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION,Japanese Journal of Pharmacology. Vol. 17, Pg. 475, 1967.
hazard_code
Xn
safety_code
22-26-36/37
Speicherklasse
11 - Combustible Solids
Giftige Stoffe Daten
142-64-3(Hazardous Substances Data)
Hazard Classifications
Aquatic Chronic 3Eye Irrit. 2Repr. 2Resp. Sens. 1Skin Irrit. 2Skin Sens. 1

52% piperazine base grades

General Manufacturing Information · 2 Einträge

Piperazine, hydrochloride (1:2): ACTIVE

INTRODUCED IN 1956 BY THE DOW CHEMICAL COMPANY AS A LIVESTOCK AND POULTRY ANTHELMINTIC.

Anwendungen

VerwendenPiperazine Dihydrochloride is an anthelmintic agent used in the treatment of parasitic worms in animals.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Piperazin-1-ethanoldihydrochlorid1,3-DIAZEPANE-2-THIONEBENZYL 1-PIPERAZINECARBOXYLATE2-(2-Aminoethylamino)ethanol

Nachgelagerte Produkte

1-Methylpiperazin1-(2-PYRIDIN-2-YL-ETHYL)-PIPERAZINE2-(4-BENZYLPIPERAZINO)BENZALDEHYDEPiperazinDibenzo[a,j]-1,4,7,10,13,16-hexaoxacyclooctadeca-2,11-dien1-Hydroxyethylethoxypiperazine1,4-PIPERAZINEDICARBONYL CHLORIDE1-(4-METHOXYBENZYL)PIPERAZINE6,7,9,10,12,13,20,21,23,24,26,27-Dodecahydrodibenz[b,n][1,4,7,10,13,16,19,22]octaoxacyclotetracosinN-METHYL-D3-PIPERAZINE1-(4-CHLOROBENZYL)PIPERAZINETrimethylboratEthylpiperazin-1-carboxylatAcetamide, 2-[2-(1-piperazinyl)ethoxy]- (9CI)